3rd Quarter - Report

SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA for HORIZON THERAPEUTICS (F/K/A) HORIZON PHARMA USA INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Federal pharmaceutical regulation

Foreign entity interest: Horizon Therapeutics is a domestic subsidiary of a foreign-parent. Although efforts are not controlled or financed by the foreign parent, all lobbying benefits the foreign parent tangentially.

LobbyistCovered position, as disclosed
CHRISTIAN BOURGE —

Contacted: White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.